These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 19684300

  • 1. Human papillomavirus genotype distributions inform screening and vaccination policy.
    Pinkowish MD.
    CA Cancer J Clin; 2009; 59(5):280-1. PubMed ID: 19684300
    [No Abstract] [Full Text] [Related]

  • 2. [Implementation of HPV vaccination in Germany].
    Schreckenberger C, Kaufmann AM, Schneider A.
    Dtsch Med Wochenschr; 2007 Oct; 132(42):2221-4. PubMed ID: 17926251
    [No Abstract] [Full Text] [Related]

  • 3. Human papillomavirus genotyping in histological sections of precursor lesions of cervical carcinoma: its role as a possible adjunct for the evaluation of the oncogenic potential of specific human papillomavirus genotypes - a study in a coastal region of southeastern Spain.
    Doménech-Peris A, Conesa-Zamora P, Sahuquillo-Frias L, Ortiz-Reina S, Moya-Biosca J, Acosta-Ortega J, Pérez-Guillermo M, Egea-Cortines M.
    Gynecol Obstet Invest; 2010 Oct; 70(2):113-9. PubMed ID: 20332645
    [Abstract] [Full Text] [Related]

  • 4. Screening: Testing times.
    Humphries C.
    Nature; 2012 Aug 30; 488(7413):S8-9. PubMed ID: 22932440
    [No Abstract] [Full Text] [Related]

  • 5. Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam.
    Domingo EJ, Noviani R, Noor MR, Ngelangel CA, Limpaphayom KK, Thuan TV, Louie KS, Quinn MA.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M71-9. PubMed ID: 18945416
    [Abstract] [Full Text] [Related]

  • 6. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
    Garland SM, Brotherton JM, Skinner SR, Pitts M, Saville M, Mola G, Jones RW.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M80-8. PubMed ID: 18945417
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of HPV 16/18 vaccines on sexually active young women and the impact on organized cervical cancer screening.
    Giorgi Rossi P, Zorzi M.
    Acta Obstet Gynecol Scand; 2010 Jun 19; 89(6):846-7; author reply 848. PubMed ID: 20504086
    [No Abstract] [Full Text] [Related]

  • 8. The case for a gender-neutral (universal) human papillomavirus vaccination policy in the United States: Point.
    Giuliano AR, Salmon D.
    Cancer Epidemiol Biomarkers Prev; 2008 Apr 19; 17(4):805-8. PubMed ID: 18398020
    [No Abstract] [Full Text] [Related]

  • 9. [Vaccination perspective against human papillomavirus and consequences for the screening of uterine cervical neoplasm].
    Delvenne P.
    Bull Mem Acad R Med Belg; 2007 Apr 19; 162(10-12):483-8; discussion 489-90. PubMed ID: 18557390
    [Abstract] [Full Text] [Related]

  • 10. Primary and secondary prevention of cervical cancer--opportunities and challenges.
    Markowitz LE, Unger ER, Saraiya M.
    J Natl Cancer Inst; 2009 Apr 01; 101(7):439-40. PubMed ID: 19318638
    [No Abstract] [Full Text] [Related]

  • 11. Modern screening in cervical cancer. Perspectives of HPV prophylactic vaccines.
    Vlădăreanu R, Andrei C.
    Rev Med Chir Soc Med Nat Iasi; 2007 Apr 01; 111(1):144-54. PubMed ID: 17595860
    [Abstract] [Full Text] [Related]

  • 12. One in four California adolescent girls have had human papillomavirus vaccination.
    Grant D, Kravitz-Wirtz N, Breen N, Tiro JA, Tsui J.
    Policy Brief UCLA Cent Health Policy Res; 2009 Feb 01; (PB2009-3):1-6. PubMed ID: 19288623
    [No Abstract] [Full Text] [Related]

  • 13. Vaccinating adolescents and young women against cancer of the cervix.
    Hilgers RD, Wyatt SW.
    J Ky Med Assoc; 2007 May 01; 105(5):215-6. PubMed ID: 17566465
    [No Abstract] [Full Text] [Related]

  • 14. Who should get the HPV vaccine?
    Pichichero ME.
    J Fam Pract; 2007 Mar 01; 56(3):197-202. PubMed ID: 17343808
    [No Abstract] [Full Text] [Related]

  • 15. The economic impact of HPV vaccines: not just cervical cancer.
    Myers ER.
    Am J Obstet Gynecol; 2008 May 01; 198(5):487-8. PubMed ID: 18455522
    [No Abstract] [Full Text] [Related]

  • 16. Models of cervical screening in the era of human papillomavirus vaccination.
    Canfell K.
    Sex Health; 2010 Sep 01; 7(3):359-67. PubMed ID: 20719228
    [Abstract] [Full Text] [Related]

  • 17. [Prevention of HPV-associated neoplasias by vaccination - short version of the German S3 (level 3) guideline].
    Gross G, Gissmann L, Hillemanns P, Ikenberg H, Kaufmann AM, Petry KU, Pfister H, Schneede P, Schneider A, Smola S, für das HPV-Management Forum.
    Dtsch Med Wochenschr; 2010 May 01; 135(21):1083-6. PubMed ID: 20486060
    [No Abstract] [Full Text] [Related]

  • 18. Screening for cervical cancer: controversy and contention or thoughtful analysis.
    Frable WJ.
    Cancer; 2007 Jun 25; 111(3):143-4. PubMed ID: 17487849
    [No Abstract] [Full Text] [Related]

  • 19. [Cervical carcinoma and the vaccination experience with Cervarix].
    Berberova M.
    Akush Ginekol (Sofiia); 2012 Jun 25; 51 Suppl 1():4-5. PubMed ID: 23236670
    [No Abstract] [Full Text] [Related]

  • 20. The quadrivalent human papillomavirus vaccine.
    Wheat A.
    Med Health R I; 2008 Dec 25; 91(12):387-9. PubMed ID: 19170317
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.